Indication and Usage: LEXIVA is indicated in combination with other antiretroviral agents for the treatment of HIV infection. The PI-experienced–patient study was not large enough to reach a definitive conclusion that LEXIVA/ritonavir and lopinavir/ritonavir are clinically equivalent. Once-daily administration of LEXIVA plus ritonavir is not recommended for PI-experienced patients or any pediatric patients. LEXIVA does not cure HIV or prevent passing HIV to others.
Important Safety Information: You should not take LEXIVA if you have had an allergic reaction to LEXIVA or AGENERASE® (amprenavir). You should not take LEXIVA with: AGENERASE® (amprenavir), Halcion® (triazolam), ergot medications (Cafergot®, Migranal®, D.H.E. 45®, and others), Propulsid® (cisapride), CONTINUED BELOW
It starts when you team up with your doctor on an HIV treatment plan. Regular checkups and blood tests will show how well your medicine is working. Together, you and your doctor are setting the goals of your HIV treatment, including:
Viral load is the amount of HIV in your blood. The goal is a viral load so low that it's undetectable
When treatment works well, your viral load goes DOWN and your T-cell (CD4 cell) count goes UP. More CD4 cells help fight off diseases, infections, and AIDS-related illnesses.
A good HIV treatment plan will control the virus without causing too many side effects
In addition to friends, family, and doctors, you have an important partner: your medicines. HIV medicines work best when used in combination with other medications. That’s because each medicine targets specific parts of the HIV lifecycle.
Entry inhibitors change the lock on the cell. The chemical HIV uses as a key no longer works, and the virus cannot enter the cell. There are two kinds of entry inhibitors: CCR5 inhibitors and fusion inhibitors (FIs).

Nucleoside reverse transcriptase inhibitors (NRTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs): NRTIs and NNRTIs slow down the rate at which copies of HIV are made in the body.

These medicines slow down the production of integrase, the chemical HIV needs to enter the cell's command center and change the cell's machinery. Without this access, HIV cannot make copies of itself.

PIs stop protease from being produced. Protease is the chemical used by HIV to form the parts that need to be put together to make a new copy of the virus. When protease production is stopped, the virus cannot make copies of itself, so it cannot infect healthy cells. LEXIVA is a protease inhibitor. See how LEXIVA, a protease inhibitor, works.

Call it "adherence," "taking as directed," or simply "sticking with it." The most important part of your treatment plan is following it every day. That's the best way to increase your chances of fighting off illness. Getting off track can cause serious problems, including viral resistance.
Don’t let the cost of HIV medicines get you off track. Check out our programs that help with the cost of HIV medication: My Support Card and the ViiV Assistance Program.
Sometimes during the course of HIV treatment, you may need to consider changing medicines. Here are possible reasons to change:
If you think it might be time to change your HIV treatment, talk to your doctor. Together, you will decide if safely changing medicines is right for you.
Talk to your doctor to see if LEXIVA is right for you.
Please see the full Prescribing Information for LEXIVA.
LEXIVA is indicated in combination with other antiretroviral agents for the treatment of HIV infection.
LEXIVA does not cure HIV or prevent passing HIV to others.